Explain this page
Arphra AIPlain-English read on ProShares - Global Listed Private Equity ETF’s valuation06-08today
- Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France11d
- Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France11d
- Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers15d
- Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers15d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →PEX
21.70-11.64%H 24.56L 20.49MA50 21.84MA200 —Avg vol 4K
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.02% | -0.44% | +1.14% | -0.12% | -14.32% | -12.24% | -21.86% | -23.24% | -42.86% | -43.26% | -46.61% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$21.70
79 sh
Bid
$19.91
3 sh
Ask
$28.17
100 sh
Spread
$8.260
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Utilities+3.33%
- Technology+2.51%
- Communication Services+1.85%
- Energy+0.42%
- Consumer Cyclical+0.27%
- Basic Materials+0.27%
- Industrials-0.12%
- Consumer Defensive-0.30%
- Financial Services-0.67%
- Real Estate-0.99%
- Healthcare-1.51%
Top industries (issuer's industry highlighted)
- Auto - Dealerships-6.22%
- Business Equipment & Supplies+5.82%
- Semiconductors+5.24%
- Advertising Agencies-5.20%
- Medical - Equipment & Services+5.08%
- Consulting Services-4.82%
- Grocery Stores-4.35%
- Internet Content & Information+3.58%
- Coal-3.56%
- Other Precious Metals-3.55%
- REIT - Diversified-3.43%
- Electrical Equipment & Parts+3.27%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in Francenewsfilecorp.com·Jun 08, 2026
- Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in Francenewsfilecorp.com·Jun 08, 2026
- Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markersnewsfilecorp.com·Jun 04, 2026
- Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markersnewsfilecorp.com·Jun 04, 2026
- Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutionsnewsfilecorp.com·May 07, 2026
Peers
No peer list available for PEX.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|